MACRA represents for Medicare a dramatic step away from traditional fee-for-service reimbursement and toward value-based payments for physician services.
The transformation to value-based care requires an organization to shift its focus from traditional care delivery to care management and coordination across disparate service lines. As part of our ongoing series of conversations about the value-based enterprise, Steve Messinger shares his thoughts on what it means to be an integrated organization in the era of reform.
Oncology providers are facing increasing pressure from payors and patients to deliver high-quality care in an efficient and economical manner. The patient-centered specialty practice is one model that has shown promise in meeting these objectives.
The PCMH model has historically focused on primary care medicine. Now the Patient-Centered Specialty Practice recognition program is aimed at aligning specialty care models with those of their primary care counterparts.
Amid healthcare’s continuing transition to value-based care delivery, many health systems are considering the possibility of developing bundled payment programs for single episodes of care. But which service is best to bundle?
The CCJR program proposed by CMS in July 2015 is accelerating the pace of payment reform, and it’s ramping up pressure on hospitals to effectively manage patients and monitor costs for joint replacements. This post spells out the program structure and physician relationship parameters.
Last week CMS proposed a Comprehensive Care for Joint Replacement model, scheduled to begin as early as next year. Is your hospital prepared to bear financial risk among your Medicare patient population for total joint replacement surgery?
To thrive in the era of health reform, organizations must do more than simply react to the changing environment. ECG's Terri Welter explains how responsive organizations are proactively designing and executing near- and long-term positioning strategies.
Faced with the dramatic escalation of healthcare costs, providers, commercial payors, and the government are testing different methodologies for reimbursing cancer care. This article by Jessica Turgon explores emerging reimbursement methodologies for cancer care and why oncology practices need to be responsive, rather than resistant, to these new payment arrangements.
Page 4 of 11